Every Form 4 that MGP Ingredients Inc (MGPI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MGPI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MGPI filings page.
Martin Roper, a director of MGP Ingredients, acquired an award of 2,924 unrestricted common shares on October 1, 2026, reported at $13.25 per share, in lieu of a cash retainer for director service. His reported post-transaction holdings were 38,427 shares, including 3,180 restricted stock units. The award was held directly.
MGP Ingredients Inc. (MGPI) reported that the Lux Children Irrevocable Trust, for which Leslie Lux serves as sole trustee and a member of a 10% holder group, sold 27,731 shares of common stock on September 16, 2026 at a weighted average price of $14.4026 per share in transactions ranging from $14.31 to $14.55. The shares were held indirectly by the trust, which now holds 0 shares; Leslie Lux may be deemed to have had sole voting and dispositive power over those shares and disclaims beneficial ownership except to the extent of her pecuniary interest.
MGP INGREDIENTS INC (MGPI) insider Paul S. Lux, reported as a member of a 10% holder group, reported an indirect sale of 33,000 shares of common stock on 2026-08-20 at a weighted average price of $17.7643 per share. The shares were sold by the Ann S. Lux 2005 Irrevocable Trust FBO Paul S. Lux, for which he is sole trustee. After these transactions, the trust beneficially owns 550,458 shares, which are included in Lux’s aggregate indirect ownership, and he may be deemed to hold sole voting and dispositive power over those shares.
MGP Ingredients President & CEO Julie Maria Francis reported that 1,994 shares of common stock were withheld on 2026-08-04 at $17.11 per share as payment of exercise price or tax liability related to equity awards. After this, she directly holds 107,836 shares, including 44,294 RSUs and 58,674 PSUs subject to time-based vesting.
Roper Martin reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients director Martin Roper received an award of 2,232 unrestricted shares of common stock, issued in lieu of a cash retainer for his board service. The shares are valued at $17.36 each. Following this grant, he directly holds 35,503 shares, including 3,180 restricted stock units.
MGP Ingredients Inc major shareholder Caroline Lux Kaplan reported two open-market sales of company common stock held indirectly through a trust. On May 26, 2026, the Ann S. Lux 2005 Irrevocable Trust FBO Caroline Lux Kaplan sold 30,000 shares at a weighted average price of $17.8225 per share. On May 27, 2026, the same trust sold another 30,000 shares at a weighted average price of $18.1791 per share, for total reported sales of 60,000 shares. Following these transactions, the trust beneficially owns 470,958 shares of MGP Ingredients common stock, over which Kaplan, as sole trustee, may be deemed to have sole voting and dispositive power.
Mingus Lori L.S. reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients Inc. director Lori L.S. Mingus received an annual award of 5,801 shares of common stock, granted as unrestricted shares for her service as a director. These shares are held directly. The filing also shows separate indirect holdings of 26,796 shares held by a trust and 419 shares held by her husband.
Lowry Jennifer Elaine reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Jennifer Elaine Lowry received an annual equity award of 5,801 shares of common stock in connection with her board service. The shares were granted at $0.00 per share as compensation rather than a market purchase. Following this grant, she directly holds 11,894 common shares, which the disclosure notes include 2,812 restricted stock units.
Roper Martin reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients director Martin Roper received an equity grant of 5,801 shares of Common Stock as an annual award for his board service. The shares were granted at no cash cost to him as compensation, not as an open‑market purchase. After this award, he directly holds 33,271 shares, including 3,180 restricted stock units.
Siwak Todd B. reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Todd B. Siwak received an annual award of 5,801 shares of common stock. The shares were granted at $0.00 per share as unrestricted stock in connection with his service as a director.
Following this grant, Siwak directly holds 10,040 shares of MGP Ingredients common stock. As of the same date, he also indirectly holds 3,046 shares through a trust.
LOPEZ GERARDO I reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Gerardo I. Lopez received an award of 5,801 shares of Common Stock as part of his annual compensation for board service. The shares were granted at no cash cost to him. Following this grant, he directly holds 12,262 shares of Common Stock, which includes 3,180 restricted stock units.
MGP Ingredients, Inc. reported that director Thomas A. Gerke received an annual award of common stock. He acquired 5,801 shares of common stock as a grant in connection with his service as a director, with no cash price per share reported in the transaction. Following this award, he directly owns 17,118 common shares. This is a compensation-related stock grant rather than an open-market purchase or sale.
Romero Mercedes reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Mercedes Romero received an annual award of 5,801 shares of common stock. The shares were granted at no cash cost as unrestricted stock in connection with her service as a director, bringing her directly held stake to 5,801 shares.
Francis Julie Maria reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients Inc. reported that President & CEO Julie Maria Francis received a grant of 150,000 stock options to buy Common Stock at $19.40 per share. The options expire on May 1, 2036 and will vest on a pro rata basis on each of May 1, 2029 and May 1, 2030.
Following this filing, Francis directly holds 109,830 shares of Common Stock, which include 51,156 restricted stock units and 58,674 performance stock units that remain subject to time-based vesting. This Form 4 reflects a compensation-related equity award rather than an open‑market trade.
MGP Ingredients director Martin Roper acquired 2,112 shares of common stock as a grant in connection with his board service. The shares were valued at $18.34 per share and were issued in lieu of a cash retainer. Following this award, he directly holds 27,470 common shares, which the footnotes state include 3,180 restricted stock units. This is a routine, compensation-related equity grant rather than an open-market purchase.
MGP Ingredients reported that Chief Legal and HR Officer Kathleen Susan Molamphy acquired two awards of common stock on March 5, 2026 as equity compensation. One grant covered 4,519 shares, and another covered 11,297 shares, each at a price of $0 per share as non-cash awards.
Footnotes explain these are restricted stock unit awards that vest pro rata over future dates, including on March 5, 2027, 2028, 2029, and 2030, and that her holdings include restricted stock units and performance stock units still subject to time-based vesting conditions.
MGP Ingredients CFO Brandon Gall reported acquiring common stock awards of the company as part of equity compensation. On March 5, 2026, he received two stock-based grant/award acquisitions totaling 8,024 and 13,955 shares of common stock at a price of $0.00 per share.
Footnotes state that one restricted stock unit award will vest on a pro rata basis on each of March 5, 2027, 2028 and 2029, and another will vest pro rata on each of March 5, 2029 and 2030. Following these awards, his directly held common stock, including restricted and performance stock units subject to time-based vesting, was reported at up to 87,278 shares.
MGP Ingredients Inc. President and CEO Julie Maria Francis reported an equity compensation award in the form of company common stock. She acquired 30,569 shares through a grant or award at a reported price of $0.0000 per share, increasing her directly owned stake to 109,830 shares.
The award is structured as restricted stock units that will vest in stages on March 5 of 2027, 2028, and 2029. Her reported holdings include 51,156 restricted stock units and 58,674 performance stock units that remain subject to a time-based vesting requirement after performance goals were certified.
MGP Ingredients reported that President and CEO Julie Maria Francis acquired 58,674 performance stock units of common stock at no cost through an equity award. The company’s compensation committee certified achievement of the award’s performance goals on February 23, 2026.
The award is still subject to time-based vesting and will fully vest on August 4, 2028. After this grant, Francis directly holds 79,261 common share equivalents, including 20,587 restricted stock units and the 58,674 performance stock units from this award.
Gall Brandon reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients CFO Brandon Gall received an equity award in the form of 13,687 performance stock units of common stock at no cash cost. The company’s committee certified the achievement of the award’s performance goals on February 23, 2026, and the units remain subject to time-based vesting.
The performance stock units will vest on February 20, 2028 if the service-based condition is met. After this grant, Gall’s directly held common stock equivalents total 65,299 shares, including 20,189 restricted stock units and the 13,687 performance stock units from this award.
Molamphy Kathleen Susan reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients' Chief Legal and HR Officer Kathleen Susan Molamphy received an equity award in the form of 5,609 performance stock units. These units were granted at no cash cost per unit after the compensation committee certified that the performance goals for the award were achieved on February 23, 2026.
The award remains subject to a time-based vesting requirement and is scheduled to vest on February 20, 2028. Following this grant, Molamphy's directly held equity consists of 12,922 units of common stock-based awards, including 7,313 restricted stock units and the 5,609 performance stock units tied to this certification.
MGP Ingredients CFO Brandon Gall reported a tax-related share disposition. On the reported date, he disposed of 598 shares of common stock at $25.93 per share in a transaction coded as a tax-withholding disposition. After this transaction, he directly owned 51,612 equity-linked interests, consisting of 31,423 shares of common stock and 20,189 restricted stock units, as noted in the footnote.
MGP Ingredients Inc. Chief Human Resources Officer Erika Lapish reported a tax-related share disposition. On February 20, 2026, she disposed of 241 shares of common stock at $25.93 per share to satisfy tax withholding obligations, a non-open-market transaction coded as a tax-withholding disposition. After this, she directly holds 9,121 shares, which the footnote states represent 6,131 common shares and 2,990 restricted stock units, and she also reports 550 shares held indirectly by her husband.
MGP Ingredients Inc. Chief Commercial Officer Amel Pasagic reported a Form 4 transaction involving company common stock. He disposed of 346 shares of common stock at $25.93 per share in a tax-withholding disposition related to payment of tax liability. Following this transaction, his directly held position is reported as 10,487 shares, which the footnote explains consists of 6,864 shares of common stock and 3,623 restricted stock units.
MGP Ingredients CFO Brandon Gall reported two tax-related share dispositions under a Form 4. On February 14, 2026, he used 1,558 shares of common stock at $25.74 per share to cover tax withholding, and on February 16, 2026, he used another 2,438 shares at the same price for the same purpose. These are coded as tax-withholding dispositions, not open-market purchases or sales. Footnotes state that his holdings include combinations of common stock and restricted stock units.
MGP Ingredients chief human resources officer Erika Lapish reported Form 4 insider transactions showing share dispositions used to cover tax obligations. She delivered 1,211 shares of common stock on February 16 and 554 shares on February 14 at $25.74 per share as tax-withholding dispositions. After these transactions, she directly owned 9,362 common shares, and footnotes indicate her holdings also include restricted stock units.
MGP Ingredients Chief Commercial Officer Amel Pasagic reported two tax-related share dispositions. On February 16, he delivered 1,527 shares of common stock at $25.74 per share to satisfy tax obligations tied to equity compensation. On February 14, he similarly delivered 744 shares at the same price for tax withholding, rather than selling shares in the open market.
Footnotes explain that his reported holdings at different times consisted of combinations of common stock and restricted stock units, including 4,114 shares and 8,246 restricted stock units in one instance and 6,278 shares and 4,555 restricted stock units in another.
MGP Ingredients Inc. (MGPI) insider Caroline L. Kaplan, a reported 10% owner, disclosed a series of open-market sales of common stock indirectly held through the Ann S. Lux 2005 Irrevocable Trust FBO Caroline Lux Kaplan.
On 11/18/2025, the trust sold 29,834 shares at a weighted average price of $23.8469 and 166 shares at a weighted average price of $24.4934. On 11/19/2025, it sold 29,860 shares at a weighted average price of $23.2755 and 140 shares at a weighted average price of $23.8079. Each price reflects multiple trades within stated ranges, and full breakdowns are available upon request.
After these transactions, 530,958 shares held by the Lux 2005 Caroline Trust are reported as indirectly beneficially owned, with Kaplan able to be deemed to have sole voting and dispositive power over those shares, while disclaiming beneficial ownership beyond her pecuniary interest.